₹-0.17
(Market cap
₹2 Cr
Revenue (TTM)
₹-- Cr
P/E Ratio
--
P/B Ratio
-0.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
0 %
-
ROCE
-0.3 %
-
Industry P/E
45.19
-
EV/EBITDA
-774.3
-
Debt to Equity
-7.6
-
Book Value
₹--
-
EPS
₹-0.1
-
Face value
10
-
Shares outstanding
4,988,500
10 Years Aggregate
CFO
₹-1.25 Cr
EBITDA
₹2.57 Cr
Net Profit
₹0.01 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Venkat Pharma
| 31.3 | -5.5 | 14.0 | 77.6 | 2.3 | -6.3 | -20.8 |
|
BSE Sensex*
| -9.2 | 2.0 | 5.8 | -6.1 | 6.9 | 8.0 | 11.0 |
|
BSE Healthcare#
| 12.0 | 2.9 | 17.7 | 13.0 | 25.0 | 14.4 | 12.5 |
|
Company
|
2014
|
|---|---|
|
Venkat Pharma
| 33.9 |
|
BSE Sensex
| 29.9 |
|
BSE Healthcare
| 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Venkat Pharma
|
3.4 | 1.7 | -- | 0.0 | -- | -- | -- | -0.7 |
| 3,265.0 | 26,802.2 | 1,339.4 | 356.4 | 33.2 | 23.2 | 75.2 | 16.2 | |
| 452.3 | 17,523.5 | 2,268.6 | 150.1 | 10.6 | 5.4 | 97.8 | 4.5 | |
| 774.0 | 19,507.8 | 5,365.6 | 595.0 | 16.6 | 13.3 | 32.8 | 3.8 | |
| 897.5 | 15,993.6 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 11.3 | 1.7 | |
| 1,558.5 | 17,968.4 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.1 | |
| 169.6 | 22,459.8 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.8 | |
| 1,416.8 | 22,947.7 | 1,284.3 | 134.4 | -- | 30.7 | 93 | 17.8 | |
| 436.8 | 17,604.0 | 3,738.7 | 316.7 | 12.5 | 7.5 | 55.6 | 3.6 | |
| 2,006.4 | 32,672.3 | 3,373.0 | 199.0 | 12.6 | 5.9 | 153.4 | 6.6 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Venkat Pharma
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1989
-
Chairman
A Ramkrishna
-
Managing Director
Saila Babu
-
Headquarters
Hyderabad, Telangana
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Venkat Pharma
What is the current share price of Venkat Pharma Ltd Today?
The share price of Venkat Pharma Ltd is ₹3.40 (BSE) as of 18-May-2015 IST. Venkat Pharma Ltd has given a return of 2.31% in the last 3 years.
What is the current PB & PE ratio of Venkat Pharma Ltd?
Since, TTM earnings of Venkat Pharma Ltd is negative, P/E ratio is not available.
The P/B ratio of Venkat Pharma Ltd is -0.66 times as on 18-May-2015, a 115 discount to its peers’ median range of 4.43 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2013
|
0.00
|
-0.49
|
|
2012
|
0.00
|
-0.48
|
|
2011
|
0.00
|
-0.68
|
|
2010
|
0.00
|
-1.00
|
|
2005
|
66.35
|
2.11
|
What is the 52 Week High and Low of Venkat Pharma Ltd?
The 52-week high and low of Venkat Pharma Ltd are Rs -- and Rs -- as of 24-Jun-2026.
What is the market cap of Venkat Pharma Ltd?
Venkat Pharma Ltd has a market capitalisation of ₹ 2 Cr as on 18-May-2015. As per SEBI classification, it is a company.
Should I invest in Venkat Pharma Ltd?
Before investing in Venkat Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.